NAGE R&D to Revenue
Niagen Bioscience Inc · R&D to Revenue
NAGE R&D to Revenue
Latest reported4.89%period ending
NAGE FY R&D/Revenue (0.00% → 4.89%)
Latest values, visible window
High-resolution chart · PNG
NAGE r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 4.8909% | |
| 6.0403% | |
| 5.9328% | |
| 6.6981% | |
| 5.6813% | |
| 5.763% | |
| 9.5483% | |
| 17.3591% | |
| 18.9001% | |
| 11.6446% | |
| 4.9852% | |
| 3.3544% | |
| 1.3192% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |